Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CDK13 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | MTRR | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | TFDP3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | AKNA | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
mRNA | TTBK2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | UTS2R | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | HIST1H2BK | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | FASTKD3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | SGSM3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | ACVR2B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |